“…Different conformational shapes for BK agonists have been proposed as a result of these investigations, e.g. random conformations (37,38), quasicyclic structures (34,39), turned structures at the N‐terminus (40), in the middle of the molecule (41,42) or at the C‐terminus (43–45). Studies with BK antagonists have suggested turned structures, in the N‐terminal sequence (between positions 2 and 5) (46,47), the C‐terminal sequence (between positions 6 and 9) (33,48,49) or in both fragments (32,35,36).…”